Skip Navigation
National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Personal tools
You are here: Home News Mouse Study Demonstrates That the Class of Drugs Known as Delta Inhibitors Stimulate an Effective Immune Response and Prevent Recurrence of a Range of Cancers
Navigation
 
Document Actions

Mouse Study Demonstrates That the Class of Drugs Known as Delta Inhibitors Stimulate an Effective Immune Response and Prevent Recurrence of a Range of Cancers

http://www.ncbi.nlm.nih.gov/pubmed/24919154

Delta inhibitors target the p110δ enzyme, which is produced by cancer cells to downregulate immune-system function. The study appears in the June 19, 2014 issue of Nature.